the pICR

from start to FINISHING CANCER

Dedicated to advancing our understanding of cancer and its causes to improve lives, the Purdue Institute for Cancer Research (PICR) is one of only seven National Cancer Institute (NCI)-designated Basic Laboratory Cancer Centers in the nation.

DISCOVERING THE PATH TO CANCER’S DEFEAT

The end of cancer begins with basic science

To defeat cancer, we must first understand it. Every breakthrough begins with a foundation built on people, purpose and persistence. At the Purdue Institute for Cancer Research (PICR), that foundation drives the discoveries behind new drugs, deeper knowledge and lifesaving advances against cancer.

900+
Scientists: faculty, students and trainees
10
Potential cancer drugs in clinical development
3
FDA-approved drugs fighting cancer now

KEY IMPACT AREAS

Often characterized by their low incidence and high complexity, pediatric and rare cancers require innovative approaches and novel solutions. The PICR leverages interdisciplinary expertise to address critical gaps in knowledge and treatment approaches, with the goal of offering new hope for patients who face limited options.

Researchers at the PICR investigate cancers that impact millions of people worldwide, including breast, prostate, lung, colorectal and bladder cancers. Our investigators work across disciplines, combining their strengths to find better ways to understand, detect, and treat cancer.

PICR researchers develop targeted cancer therapies that attack tumors with precision while reducing harmful side effects.  Our work addresses major challenges, including drug resistance and aggressive cancer subtypes.

PICR researchers are developing innovative tools and strategies to prevent cancer and detect it in its earliest stages, when treatment is most effective. This impact area underscores the institute’s commitment to reducing the burden of cancer by addressing risk factors, advancing preventive measures, and improving early detection through collaborative scientific discovery.

Through the study of naturally occurring cancers in companion animals, veterinary medicine and comparative oncology provide critical insights into the biology, progression, and treatment of malignancies across species. Clinical research in pet patients enhances the standard of care in veterinary oncology while generating translational knowledge that expedites the development and refinement of more effective cancer therapies for human patients.

Personalized medicine tailors cancer treatment to the unique genetic and molecular features of each patient and their tumor. Researchers at the PICR are uncovering the biological drivers of cancer to guide more precise, effective and individualized therapies.

Fundamental discoveries are the engine that drives cancer research at the PICR. As an NCI-designated basic science center, we uncover what causes cancer and turn this knowledge into novel breakthroughs to detect and treat the disease—pushing the boundaries of what’s possible through bold, collaborative science.

Andrew Mesecar

Robert Wallace Miller Director of the Purdue Institute for Cancer Research, Distinguished Professor of Biochemistry, Walther Professor in Cancer Structural Biology

Tyler Trent’s life and legacy transform passion into impact

In creating the Tyler Trent Pediatric Cancer Research Center, the PICR combines deep strengths in multiple research fields to fight childhood cancers and to beat osteosarcoma, the rare bone cancer that took the life of beloved Purdue alumnus and superfan, Tyler Trent. 

A history of innovation

For nearly half a century, PICR has been at the forefront of scientific discovery, recognized since 1978 for its scientific excellence as 1 of only 7 National Cancer Institute (NCI)-designated basic laboratory cancer centers in the nation.

One Health reveals deeper connections in cancer science

Purdue’s One Health Initiative integrates cancer research into a broader effort to understand the shared drivers of human, animal and plant health.

Stories & Highlights

Explore stories, updates and highlights that showcase our discoveries, celebrate our people and share the impact of PICR research.

Events

Stay connected with upcoming events that bring our research community together and spotlight the work driving progress against cancer.

Connect with us

There’s more to discover on social

Contact Us

Get in touch

Phone: 765-494-9129
Fax: 765-494-9193
Email: cancerresearch@purdue.edu

Find us

201 S. University St.
Hansen Life Sciences Bldg, Rm. 141
West Lafayette, IN 47907